CD4 and neoplasm: Notably, although there is a significant increase in the percentages of Treg cells which suppressed tumor-specific immune responses, there is also a substantial increase in the percentages of Tconv cells, with marked enhancement of the CD4 effectors to Treg ratios, which has been previously demonstrated to be a marker of a favorable immunological response14,42.